A drug being developed by Targacept and AstraZeneca to fight major depressive disorder failed to meet its goal in a second Phase 3 clinical trial, according to an announcement. The drug, known as TC-5214, performed well [...]
Posted On : Dec, 22 2011 | Comments : 0